The present investigation was designed to determine whether atrial natriuretic peptides (ANPs) consisting of amino acids 1-30 [i.e. long-acting natriuretic hormone (LANH)], 31-67 (vessel dilator), 79 -98 (kaliuretic hormone), and 99 -126 (atrial natriuretic hormone [ANH]) of the 126-amino acid ANH prohormone decrease the circulating concentrations of total and free T 4 and/or free T 3 in healthy humans (n ؍ 30). Vessel dilator, kaliuretic hormone, LANH, and ANH decreased the circulating concentrations of total T 4 by 61%, 58%, 47%, and 55% and of free T 4 by 60%, 67%, 79%, and 79%, whereas free T 3 decreased 72%, 67%, 71%, and 67% (P < 0.05 for each), respectively, when infused at 100 ng/kg BW⅐min for 60 min. Vessel -(99 -126); ANH) of the 126-aa prohormone (5). With respect to clinical correlation, hypothyroid subjects have decreased circulating concentrations of LANH, vessel dilator, and ANH (collectively termed ANPs) (6 -10). On the other hand, hyperthyroid individuals have 2-to 4-fold increased circulating concentrations of ANPs compared with healthy subjects (6 -10). These peptide hormones also increase proportionally in the circulation of hypothyroid subjects with increasing replacement doses of l-T 4 of 50 and 100 g/d (10). When hypothyroid patients become euthyroid with T 4 treatment, the circulating levels of ANPs increase to those of normal healthy adults (10).ANH, on the other hand, inhibits the TSH-induced increase of radioiodine levels in the mouse (11). Binding sites for ANH have been found on human thyroid follicular cells in culture (12,13). These studies suggest that ANH and possibly the other ANPs may inhibit thyroid hormone secretion from the thyroid gland. The present investigation was designed to determine whether infusion of ANH, vessel dilator, LANH, and/or kaliuretic hormone decrease the circulating concentrations of total and free T 4 and/or free T 3 . When each of these peptide hormones decreased the circulating concentration of free and total T 4 and free T 3 , the concentration of TSH was measured in the same plasma samples to help determine whether the decreases in T 4 and T 3 in the circulation were due to a direct effect(s) of these ANPs on the thyroid and/or possibly by decreasing the circulating concentration of TSH.
Subjects and Methods
Experimental subjectsThirty healthy subjects (15 men and 15 women; aged 20 -58 yr; average, 32 yr; all normotensive with blood pressures Ͻ125/80 mm Hg) were studied. These subjects had heart rates ranging from 56 -80 beats/ min, with respiration rates between 12-14/min. These 30 volunteers were divided into 5 similar groups with 6 individuals in each group. The age, weight, blood pressure, and heart rates for each group are outlined in Table 1. None of the volunteers had any known disease. None of the volunteers was taking any medication. Written informed consent was obtained from each of the volunteers after the nature and possible consequences of the studies were fully explained. This study was approved by the institutional review board of t...